Jeff Ajer
2017
In 2017, Jeff Ajer earned a total compensation of $4.6M as Executive Vice President, Chief Commercial Officer at BioMarin Pharmaceutical, a 3% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $451,560 |
|---|---|
| Option Awards | $1,439,891 |
| Salary | $524,231 |
| Stock Awards | $2,133,048 |
| Other | $19,572 |
| Total | $4,568,302 |
Ajer received $2.1M in stock awards, accounting for 47% of the total pay in 2017.
Ajer also received $451.6K in non-equity incentive plan, $1.4M in option awards, $524.2K in salary and $19.6K in other compensation.
Rankings
In 2017, Jeff Ajer's compensation ranked 2,147th out of 14,666 executives tracked by ExecPay. In other words, Ajer earned more than 85.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,147 out of 14,666 | 85th |
Division Manufacturing | 733 out of 5,770 | 87th |
Major group Chemicals And Allied Products | 196 out of 2,074 | 91st |
Industry group Drugs | 149 out of 1,730 | 91st |
Industry Pharmaceutical Preparations | 115 out of 1,329 | 91st |
Source: SEC filing on April 23, 2019.
Ajer's colleagues
We found four more compensation records of executives who worked with Jeff Ajer at BioMarin Pharmaceutical in 2017.
2017
Jean-Jacques Bienaim
BioMarin Pharmaceutical
Chief Executive Officer
2017
Henry Fuchs
BioMarin Pharmaceutical
President, Worldwide R&D
2017
Daniel Spiegelman
BioMarin Pharmaceutical
Chief Financial Officer
2017
Robert Baffi
BioMarin Pharmaceutical
Executive Vice President, Technical Operations
News
BioMarin Pharmaceutical CEO Jean-Jacques Bienaim's 2021 pay rises 1% to $18M
April 12, 2022
BioMarin Pharmaceutical CEO Jean-Jacques Bienaim's 2020 pay slips 2% to $18M
April 13, 2021
BioMarin Pharmaceutical CEO Jean-Jacques Bienaim's 2019 pay rises 18% to $18M
April 14, 2020
BioMarin Pharmaceutical CEO Jean-Jacques Bienaim's 2018 pay slips 2% to $16M
April 23, 2019